Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01579682 · ClinicalTrials.gov registry record · NA
Adaptive Family Treatment for Adolescent Anorexia Nervosa
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01579682: Completed NA study, sponsored by Stanford University.
NCT01579682 is a NA study that has completed, run by Stanford University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01579682, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Anorexia Nervosa (AN) has the highest mortality rate compared to any other psychiatric disorder. The most promising treatment for adolescents with AN is family-based treatment (FBT). However, only 50% of patients receiving FBT fully remit at 12-month follow-up. Consequently, providing an alternative therapy early in the treatment course for those not responding to FBT may enhance overall outcome. This study aims to develop a new treatment - Intensive Family-Focused Treatment (IFT) - to improve outcomes in those adolescents, aged 12-18 years, who do not show an early response to FBT.
Primary Outcome
Weight restoration to at least 95% of Median body weight (calculated by height, weight, gender, and age)
Interventions
- BEHAVIORAL Family-Based Therapy (FBT)
- BEHAVIORAL Family-Based Therapy with Intensive Family-Focused treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT01579682 record still lists
NCT01579682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Family-Based Therapy (FBT) is the first listed.
NCT01579682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01579682 about?
NCT01579682 is a clinical study titled "Adaptive Family Treatment for Adolescent Anorexia Nervosa". Anorexia Nervosa (AN) has the highest mortality rate compared to any other psychiatric disorder. The most promising treatment for adolescents with AN is family-based treatment (FBT). However, only 50% of patients receiving FBT fully remit at 12-month follow-up. Consequently, providing an alternative...
What is the current status of trial NCT01579682?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01579682?
The interventions under investigation include: Family-Based Therapy (FBT) (BEHAVIORAL), Family-Based Therapy with Intensive Family-Focused treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01579682?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01579682's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia